Search Orphan Drug Designations and Approvals
-
Generic Name: | recombinant human anti-human Sortilin (SORT1) monoclonal IgG1 G1m17,1 [or G1m (z,a)] kappa monoclonal antibody |
---|---|
Date Designated: | 06/18/2018 |
Orphan Designation: | Treatment of Frontotemporal Dementia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Alector 151 Oyster Point Boulevard Suite 300 South San Francisco, California 94080 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-